COMMUNIQUÉS West-GlobeNewswire

Extendicare Announces January 2026 Dividend of C$0.042 per Share
15/01/2026
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of [...]
HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting
15/01/2026
Company Shared Poster on Breakthrough Genetic Stratification Data from Positive Phase 2b OLIVE Trial Results for BH-200 MUNICH, Germany, Jan. 15, 2026 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC”), a clinical-stage [...]
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
15/01/2026
WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne [...]
Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
15/01/2026
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. control There are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2 clinical trials to date [...]
Sienna Announces January Dividend
15/01/2026
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers
15/01/2026
GT Biopharma targets a portion of the estimated $362 billion global solid tumor market Preliminary, unaudited cash balance of approximately $7 million as of December 31, 2025 anticipated to extend cash runway into Q3 [...]
Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
15/01/2026
The Science, Clinical Promise, & Market Outlook MELBOURNE, Australia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on [...]
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
15/01/2026
TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, [...]
Adaptin Bio to Present at the 2026 Sequire Investor Summit in Puerto Rico
15/01/2026
CHARLOTTE, N.C., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio , Inc. (“Adaptin” or the “Company”), a biotechnology company focused on developing precision cancer therapies with targeted delivery to the brain and other [...]
Precipio Takes Major Steps Toward a Clean Balance Sheet
15/01/2026
Less than $80,000 of long-term debt, and 10,000 vendor warrants remain outstanding NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has made major [...]
Phonak Virto R Infinio recognized in the 2026 BIG Innovation Awards for redefining custom hearing
15/01/2026
STÄFA, Switzerland, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Phonak , a global leader in innovative hearing solutions, today announced that Virto R Infinio has been named an Innovative Product Winner in the 2026 BIG Innovation [...]
Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting
15/01/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 15 JANUARY 2026 at 16:30 EET Recommendation by the Orion Nomination Committee on the proposals to be [...]
14th Annual State of the Cure for T1D Shows Major Development in Cure Research
15/01/2026
NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit solely focused on accelerating a cure for type 1 diabetes, announced the release of the 14 th annual State of the [...]
Zelluna ASA: Approval and publication of prospectus
15/01/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. [...]
Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
15/01/2026
Recently IND-Cleared HER2 × CD3 T-Cell Engager Highlighted by Global Biopharmaceutical Partner BURLINGTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq: ABP), a clinical-stage biotechnology [...]
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia
15/01/2026
NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced the first [...]
AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa
15/01/2026
This milestone marks significant progress in the first-in-human evaluation of AAVantgarde’s dual-AAV gene therapy designed to address the underlying cause of vision loss in patients with USH1B LONDON and MILAN, Jan. 15 [...]
Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date
15/01/2026
Amendment adds incremental $25,000,000 and extends maturity date from September 29, 2028 to February 28, 2029 CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or [...]
Verdane Invests in Clue to Accelerate the Future of Women’s Health
15/01/2026
BERLIN, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Clue, the #1 women-led period and cycle tracker health and wellness app, with over 100 million downloads worldwide, today announced a significant and strategic investment from [...]

Pages